CVS Health Corp. closed $34.74 short of its 52-week high ($80.75), which the company reached on March 28th.
CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging margins.
Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of ...
In a report released today, Charles Rhyee from TD Cowen maintained a Hold rating on CVS Health (CVS – Research Report), with a price target of ...
The University of Charleston announced the closure of its School of Pharmacy due to declining enrollment, reflecting national ...
The latest trading session saw CVS Health (CVS) ending at $45.78, denoting a -0.09% adjustment from its last day's close. This change was narrower than the S&P 500's 1.11% loss on the day. Meanwhile, ...